In: PATENT NEWS
Law360, New York (January 19, 2018, 2:10 PM EST) — The Federal Circuit on Thursday held firm in its decision to invalidate a patent covering Merck’s antibiotic Invanz, which was being challenged by Pfizer Inc. unit Hospira, despite arguments from Merck that the patent came from unique research.
In: PATENT NEWS
Law360, New York (January 19, 2018, 1:58 PM EST) — The Federal Circuit has given Teva Pharmaceuticals until Monday to reply to Helsinn Healthcare’s last-ditch bid to keep Teva from launching a generic version of Helsinn’s Aloxi anti-nausea drug while it seeks to take its patent case to the U.S. …
In: COPYRIGHT NEWS
Now Another Judge Smacks Around A Guardaley Shell Company Acting As A Copyright Troll Techdirt Full coverage
In: PATENT NEWS
On January 8 2018 in Wi-Fi One, LLC v Broadcom Corp the US Court of Appeals for the Federal Circuit sitting en banc issued a majority opinion holding that a determination made by the US Patent and Trademark Office (USPTO) concerning whether a petition for an inter partes review is... Continue reading
In: PATENT NEWS
The UK Patents Court has decided that the commitment made by a holder of standards essential patents (SEPs) to license on fair, reasonable and non-discriminatory (FRAND) terms is enforceable separately from any obligation to license based on competition law and that there can be only one set of …
In: PATENT NEWS
Rockefeller, Broad Settle CRISPR IP Dispute; EPO Denies Broad European Patent GenomeWeb Arbitrator tells Rockefeller to stop blocking Broad Institute of MIT and Harvard CRISPR-Cas9 system patent Science Codex Full coverage
In: TRADEMARK NEWS
Six key trademark filing and protection strategies in 2018 International Law Office Full coverage
In: TRADEMARK NEWS
Most brands experienced trademark infringement in past year – report Netimperative Full coverage
In: TRADEMARK NEWS
NCAA scores victory in trademark infringement case Indiana Lawyer Full coverage
In: TRADEMARK NEWS
Trademark dispute between Splenda, Applebees and IHOP to continue Indiana Lawyer Full coverage
Designed by Industrial Action
Copyright © 2024 OPUS IP Limited. All Rights Reserved
OPUS IP Limited: COMPANY & OTHER LEGAL INFORMATION